Medifast, Inc.
MED
$12.36
$0.534.48%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -15.30% | -8.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.30% | -8.79% | |||
| Cost of Revenue | -5.75% | -8.17% | |||
| Gross Profit | -18.90% | -9.02% | |||
| SG&A Expenses | -14.97% | -9.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.32% | -8.86% | |||
| Operating Income | -282.83% | 15.53% | |||
| Income Before Tax | -192.42% | 446.58% | |||
| Income Tax Expenses | -200.25% | -69.57% | |||
| Earnings from Continuing Operations | -191.17% | 421.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -191.17% | 421.24% | |||
| EBIT | -282.83% | 15.53% | |||
| EBITDA | -121.11% | 47.62% | |||
| EPS Basic | -191.18% | 420.00% | |||
| Normalized Basic EPS | -192.42% | 445.00% | |||
| EPS Diluted | -195.45% | 412.06% | |||
| Normalized Diluted EPS | -192.98% | 441.67% | |||
| Average Basic Shares Outstanding | 0.00% | 0.39% | |||
| Average Diluted Shares Outstanding | -0.62% | 1.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -1.00% | 1.00% | |||